PulseAugur
LIVE 10:18:59
frontier release · [1 source] ·
0
frontier release

OpenAI launches GPT-Rosalind to accelerate life sciences research and drug discovery

OpenAI has launched GPT-Rosalind, a specialized AI model designed to accelerate research and drug discovery in the life sciences. This new model enhances scientific workflows by improving tool use and deepening understanding across chemistry, genomics, and protein engineering. GPT-Rosalind is now available through ChatGPT, Codex, and the API for select customers, with a research plugin also released for Codex. AI

Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →

RANK_REASON OpenAI, a frontier lab, has released a new purpose-built model, GPT-Rosalind, for a specific domain (life sciences).

Read on OpenAI News →

OpenAI launches GPT-Rosalind to accelerate life sciences research and drug discovery

COVERAGE [1]

  1. OpenAI News TIER_1 ·

    Introducing GPT-Rosalind for life sciences research

    OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.